Amgen Statistics

Total Valuation

Amgen has a market cap or net worth of BRL 872.11 billion. The enterprise value is 1.14 trillion.

Market Cap	872.11B
Enterprise Value	1.14T

Important Dates

The next estimated earnings date is Monday, August 4, 2025.

Earnings Date	Aug 4, 2025
Ex-Dividend Date	May 15, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.88%
Shares Change (QoQ)	-0.18%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	536.33M

Valuation Ratios

The trailing PE ratio is 25.64 and the forward PE ratio is 14.44.

PE Ratio	25.64
Forward PE	14.44
PS Ratio	4.46
PB Ratio	24.51
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.07, with an EV/FCF ratio of 18.17.

EV / Earnings	33.44
EV / Sales	6.10
EV / EBITDA	13.07
EV / EBIT	20.29
EV / FCF	18.17

Financial Position

The company has a current ratio of 1.17, with a Debt / Equity ratio of 9.24.

Current Ratio	1.17
Quick Ratio	0.74
Debt / Equity	9.24
Debt / EBITDA	3.60
Debt / FCF	5.26
Interest Coverage	2.88

Financial Efficiency

Return on equity (ROE) is 105.67% and return on invested capital (ROIC) is 9.67%.

Return on Equity (ROE)	105.67%
Return on Assets (ROA)	7.04%
Return on Invested Capital (ROIC)	9.67%
Return on Capital Employed (ROCE)	15.47%
Revenue Per Employee	6.99M
Profits Per Employee	1.21M
Employee Count	28,000
Asset Turnover	0.37
Inventory Turnover	1.37

Taxes

In the past 12 months, Amgen has paid 4.11 billion in taxes.

Income Tax	4.11B
Effective Tax Rate	10.78%

Stock Price Statistics

The stock price has decreased by -3.83% in the last 52 weeks. The beta is 0.50, so Amgen's price volatility has been lower than the market average.

Beta (5Y)	0.50
52-Week Price Change	-3.83%
50-Day Moving Average	56.36
200-Day Moving Average	60.26
Relative Strength Index (RSI)	55.42
Average Volume (20 Days)	533

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.54

Income Statement

In the last 12 months, Amgen had revenue of BRL 195.66 billion and earned 34.02 billion in profits. Earnings per share was 62.74.

Revenue	195.66B
Gross Profit	135.14B
Operating Income	58.85B
Pretax Income	38.13B
Net Income	34.02B
EBITDA	90.17B
EBIT	58.85B
Earnings Per Share (EPS)	62.74

Full Income Statement

Balance Sheet

The company has 50.51 billion in cash and 328.99 billion in debt, giving a net cash position of -278.48 billion.

Cash & Cash Equivalents	50.51B
Total Debt	328.99B
Net Cash	-278.48B
Net Cash Per Share	n/a
Equity (Book Value)	35.59B
Book Value Per Share	66.19
Working Capital	22.48B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 69.90 billion and capital expenditures -7.32 billion, giving a free cash flow of 62.58 billion.

Operating Cash Flow	69.90B
Capital Expenditures	-7.32B
Free Cash Flow	62.58B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 69.07%, with operating and profit margins of 30.08% and 17.39%.

Gross Margin	69.07%
Operating Margin	30.08%
Pretax Margin	19.49%
Profit Margin	17.39%
EBITDA Margin	46.08%
EBIT Margin	30.08%
FCF Margin	31.98%

Dividends & Yields

This stock pays an annual dividend of 1.29, which amounts to a dividend yield of 2.21%.

Dividend Per Share	1.29
Dividend Yield	2.21%
Dividend Growth (YoY)	20.27%
Years of Dividend Growth	11
Payout Ratio	82.64%
Buyback Yield	-0.88%
Shareholder Yield	1.32%
Earnings Yield	3.90%
FCF Yield	7.18%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on October 29, 2020. It was a forward split with a ratio of 28.

Last Split Date	Oct 29, 2020
Split Type	Forward
Split Ratio	28

Scores

Amgen has an Altman Z-Score of 1.56 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.56
Piotroski F-Score	6